-
Je něco špatně v tomto záznamu ?
Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium
BV. Balgobind, J. Visser, M. Grehn, M. Marquard Knap, D. de Ruysscher, M. Levis, P. Alcantara, J. Boda-Heggemann, M. Both, S. Cozzi, J. Cvek, EMT. Dieleman, O. Elicin, N. Giaj-Levra, R. Jumeau, D. Krug, M. Algara López, M. Mayinger, F. Mehrhof,...
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
- MeSH
- benchmarking MeSH
- komorová tachykardie * radioterapie chirurgie MeSH
- koronární cévy MeSH
- lidé MeSH
- plánování radioterapie pomocí počítače * metody MeSH
- srdce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND PURPOSE: In patients with recurrent ventricular tachycardia (VT), STereotactic Arrhythmia Radioablation (STAR) shows promising results. The STOPSTORM.eu consortium was established to investigate and harmonise STAR treatment in Europe. The primary goals of this benchmark study were to standardise contouring of organs at risk (OAR) for STAR, including detailed substructures of the heart, and accredit each participating centre. MATERIALS AND METHODS: Centres within the STOPSTORM.eu consortium were asked to delineate 31 OAR in three STAR cases. Delineation was reviewed by the consortium expert panel and after a dedicated workshop feedback and accreditation was provided to all participants. Further quantitative analysis was performed by calculating DICE similarity coefficients (DSC), median distance to agreement (MDA), and 95th percentile distance to agreement (HD95). RESULTS: Twenty centres participated in this study. Based on DSC, MDA and HD95, the delineations of well-known OAR in radiotherapy were similar, such as lungs (median DSC = 0.96, median MDA = 0.1 mm and median HD95 = 1.1 mm) and aorta (median DSC = 0.90, median MDA = 0.1 mm and median HD95 = 1.5 mm). Some centres did not include the gastro-oesophageal junction, leading to differences in stomach and oesophagus delineations. For cardiac substructures, such as chambers (median DSC = 0.83, median MDA = 0.2 mm and median HD95 = 0.5 mm), valves (median DSC = 0.16, median MDA = 4.6 mm and median HD95 = 16.0 mm), coronary arteries (median DSC = 0.4, median MDA = 0.7 mm and median HD95 = 8.3 mm) and the sinoatrial and atrioventricular nodes (median DSC = 0.29, median MDA = 4.4 mm and median HD95 = 11.4 mm), deviations between centres occurred more frequently. After the dedicated workshop all centres were accredited and contouring consensus guidelines for STAR were established. CONCLUSION: This STOPSTORM multi-centre critical structure contouring benchmark study showed high agreement for standard radiotherapy OAR. However, for cardiac substructures larger disagreement in contouring occurred, which may have significant impact on STAR treatment planning and dosimetry evaluation. To standardize OAR contouring, consensus guidelines for critical structure contouring in STAR were established.
Department for Radiation Oncology Charité Universitätsmedizin Berlin Berlin Germany
Department of Cardiology Amsterdam UMC location University of Amsterdam Amsterdam the Netherlands
Department of Oncology Aarhus University Hospital Aarhus Denmark
Department of Oncology University Hospital and Faculty of Medicine Ostrava Czech Republic
Department of Oncology University of Torino Torino Italy
Department of Radiation Oncology Catharina Hospital Eindhoven the Netherlands
Department of Radiation Oncology Hospital General Valencia Valencia Spain
Department of Radiation Oncology University Hospital of Zurich Zurich Switzerland
Department of Radiation Oncology University Medical Center Schleswig Holstein Kiel Germany
Department of Radio Oncology Lausanne University Hospital Lausanne Switzerland
Department of Radiology and Neuroradiology University Medical Center Schleswig Holstein Kiel Germany
Department of Radiotherapy Hospital del Mar Universitat Pompeu Fabra Barcelona Spain
Department of Radiotherapy University Medical Center Utrecht Utrecht the Netherlands
Radiation Oncology Clinical Department National Center of Oncological Hadrontherapy Pavia Italy
Radiation Oncology Department Centre Léon Bérard Lyon France
Radiation Oncology Unit Azienda USL IRCCS Reggio Emilia Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000426
- 003
- CZ-PrNML
- 005
- 20240213093156.0
- 007
- ta
- 008
- 240109e20231010ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.radonc.2023.109949 $2 doi
- 035 __
- $a (PubMed)37827279
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Balgobind, Brian V $u Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands. Electronic address: b.v.balgobind@amsterdamumc.nl
- 245 10
- $a Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium / $c BV. Balgobind, J. Visser, M. Grehn, M. Marquard Knap, D. de Ruysscher, M. Levis, P. Alcantara, J. Boda-Heggemann, M. Both, S. Cozzi, J. Cvek, EMT. Dieleman, O. Elicin, N. Giaj-Levra, R. Jumeau, D. Krug, M. Algara López, M. Mayinger, F. Mehrhof, M. Miszczyk, MJ. Pérez-Calatayud, LHG. van der Pol, PP. van der Toorn, V. Vitolo, PG. Postema, E. Pruvot, JC. Verhoeff, O. Blanck
- 520 9_
- $a BACKGROUND AND PURPOSE: In patients with recurrent ventricular tachycardia (VT), STereotactic Arrhythmia Radioablation (STAR) shows promising results. The STOPSTORM.eu consortium was established to investigate and harmonise STAR treatment in Europe. The primary goals of this benchmark study were to standardise contouring of organs at risk (OAR) for STAR, including detailed substructures of the heart, and accredit each participating centre. MATERIALS AND METHODS: Centres within the STOPSTORM.eu consortium were asked to delineate 31 OAR in three STAR cases. Delineation was reviewed by the consortium expert panel and after a dedicated workshop feedback and accreditation was provided to all participants. Further quantitative analysis was performed by calculating DICE similarity coefficients (DSC), median distance to agreement (MDA), and 95th percentile distance to agreement (HD95). RESULTS: Twenty centres participated in this study. Based on DSC, MDA and HD95, the delineations of well-known OAR in radiotherapy were similar, such as lungs (median DSC = 0.96, median MDA = 0.1 mm and median HD95 = 1.1 mm) and aorta (median DSC = 0.90, median MDA = 0.1 mm and median HD95 = 1.5 mm). Some centres did not include the gastro-oesophageal junction, leading to differences in stomach and oesophagus delineations. For cardiac substructures, such as chambers (median DSC = 0.83, median MDA = 0.2 mm and median HD95 = 0.5 mm), valves (median DSC = 0.16, median MDA = 4.6 mm and median HD95 = 16.0 mm), coronary arteries (median DSC = 0.4, median MDA = 0.7 mm and median HD95 = 8.3 mm) and the sinoatrial and atrioventricular nodes (median DSC = 0.29, median MDA = 4.4 mm and median HD95 = 11.4 mm), deviations between centres occurred more frequently. After the dedicated workshop all centres were accredited and contouring consensus guidelines for STAR were established. CONCLUSION: This STOPSTORM multi-centre critical structure contouring benchmark study showed high agreement for standard radiotherapy OAR. However, for cardiac substructures larger disagreement in contouring occurred, which may have significant impact on STAR treatment planning and dosimetry evaluation. To standardize OAR contouring, consensus guidelines for critical structure contouring in STAR were established.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a plánování radioterapie pomocí počítače $x metody $7 D011880
- 650 _2
- $a benchmarking $7 D019985
- 650 _2
- $a srdce $7 D006321
- 650 _2
- $a koronární cévy $7 D003331
- 650 12
- $a komorová tachykardie $x radioterapie $x chirurgie $7 D017180
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Visser, Jorrit $u Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Grehn, Melanie $u Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Marquard Knap, Marianne $u Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
- 700 1_
- $a de Ruysscher, Dirk $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University, Maastricht, the Netherlands
- 700 1_
- $a Levis, Mario $u Department of Oncology, University of Torino, Torino, Italy
- 700 1_
- $a Alcantara, Pino $u Department of Radiation Oncology, Hospital Clínico San Carlos, Faculty of Medicine, University Complutense of Madrid, Madrid, Spain
- 700 1_
- $a Boda-Heggemann, Judit $u Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
- 700 1_
- $a Both, Marcus $u Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Cozzi, Salvatore $u Radiation Oncology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy; Radiation Oncology Department, Centre Léon Bérard, Lyon, France
- 700 1_
- $a Cvek, Jakub $u Department of Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic
- 700 1_
- $a Dieleman, Edith M T $u Department of Radiation Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Elicin, Olgun $u Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 700 1_
- $a Giaj-Levra, Niccolò $u Department of Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy
- 700 1_
- $a Jumeau, Raphaël $u Department of Radio-Oncology, Lausanne University Hospital, Lausanne, Switzerland
- 700 1_
- $a Krug, David $u Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Algara López, Manuel $u Department of Radiotherapy, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain
- 700 1_
- $a Mayinger, Michael $u Department of Radiation Oncology, University Hospital of Zurich, Zurich, Switzerland
- 700 1_
- $a Mehrhof, Felix $u Department for Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany
- 700 1_
- $a Miszczyk, Marcin $u IIIrd Radiotherapy and Chemotherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland
- 700 1_
- $a Pérez-Calatayud, Maria José $u Department of Radiation Oncology, Hospital General Valencia, Valencia, Spain
- 700 1_
- $a van der Pol, Luuk H G $u Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands
- 700 1_
- $a van der Toorn, Peter-Paul $u Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands
- 700 1_
- $a Vitolo, Viviana $u Radiation Oncology Clinical Department, National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy
- 700 1_
- $a Postema, Pieter G $u Department of Cardiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Pruvot, Etienne $u Heart and Vessel Department, Service of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Verhoeff, Joost C $u Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands
- 700 1_
- $a Blanck, Oliver $u Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany
- 773 0_
- $w MED00004049 $t Radiotherapy and oncology $x 1879-0887 $g Roč. 189 (20231010), s. 109949
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37827279 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093153 $b ABA008
- 999 __
- $a ok $b bmc $g 2049222 $s 1210120
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 189 $c - $d 109949 $e 20231010 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
- LZP __
- $a Pubmed-20240109
